Outcome of patients with HER2-positive breast cancer treated with or without adjuvant trastuzumab in the Finland Capecitabine Trial (FinXX)Heikki Joensuu, Henrik Lindman, Riikka Huovinen et al.|Acta Oncologica|2013Cited by 24